Immunogenicity of human-induced pluripotent stem cell-derived cardiomyocyte sheets

Researchers employ in-vitro assays and immunodeficient mice to investigate the associated immune response mechanism

2024-07-10

(Press-News.org)

Ischemic heart disease stands as a significant global cause of morbidity and mortality. One promising avenue for treatment involves human induced pluripotent stem cell-derived cardiomyocytes (hiPS-CMs). Derived from adult somatic cells such as blood or skin cells, hiPS cells possess the capacity to differentiate into various tissues, including cardiomyocytes. These cells can potentially repair damaged heart tissue, but their clinical application is limited due to concerns about immune rejection. Understanding the immunogenicity of hiPS-CMs is crucial for advancing their therapeutic use.

To address this gap, a team of researchers led by PhD student Ryu Matsumoto, affiliated with the Center for Immune Therapeutics and Diagnosis at Juntendo University Graduate School of Medicine, Tokyo, Japan, and also a clinical surgeon in the Department of Digestive Surgery, Breast and Thyroid Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan, pioneered a novel humanized mouse model designed to explore immune responses to hiPS-CMs. The study was co-led by Assistant Professor Yin Enzhi and involved Associate Professor Koichiro Uchida, both from the Center for Immune Therapeutics and Diagnosis at Juntendo University Graduate School of Medicine, Tokyo, Japan. Their findings were published online on April 22, 2024 in The Journal of Heart and Lung Transplantation.

Explaining the motivation behind the present research, Matsumoto says, “Being a surgeon, I am highly aware of the critical shortage of donor hearts for patients with advanced cardiovascular disease. Although transplantation of hiPS-CM sheets could be a novel therapeutic option, the issue of immune rejection against these sheets poses a significant barrier to their clinical safety and efficacy. Therefore, a humanized mouse model could be a valuable tool to predict and understand this immunological rejection, paving the way for safer and more effective transplantation procedures involving hiPS-CM sheets.” The team began by engineering the hPBMC-NOG-ΔMHC mice through rigorous genetic modifications and precise experimental procedures.

The NOG-ΔMHC mice are created by combining the immunodeficient characteristics of NOG mice with a crucial alteration: the elimination of major histocompatibility complex (MHC) class I and class II expression. This genetic modification plays a pivotal role in reducing the potential for immune rejection of transplanted human cells, thereby enabling more effective research into cell-based therapies. Now, the researchers "humanized" these immunodeficient mice by introducing human peripheral blood mononuclear cells (hPBMCs) into them. This innovative approach enhances the model's relevance for studying human immune reactions and evaluating therapeutic strategies involving human cell transplants.

In vitro experiments revealed that hiPS-CMs express only human leukocyte antigen (HLA) class I molecules and induce a limited immune response. However, the hiPS-CM sheets were rejected around 17 to 24 days after transplantation in hPBMC-NOG-ΔMHC mice model. This rejection was primarily orchestrated by CD8+ T cells, a type of immune cells responsible for directly attacking foreign or infected cells. These CD8+ T cells infiltrated the graft site and were found to produce increased levels of IFN-γ (interferon-gamma), a molecule produced by the immune system that helps activate immune responses.

Importantly, this immune-mediated rejection was not evident in the absence of hPBMC transfer into the mice, underscoring the critical role of these immune cells in mounting an anti-graft response. The study further demonstrated that depletion of CD8+ T cells or treatment with tacrolimus, an immunosuppressive drug, significantly prolonged the survival of the hiPS-CM sheets within the hPBMC-NOG-ΔMHC mice, emphasizing the pivotal role of CD8+ T cells in the rejection process.

Delving into the real-world applications of their research findings, Matsumoto says, “Our research paves the way for developing optimal immunosuppression strategies, potentially making hiPS-CM sheets transplant a reality for many patients with severe heart failure in the near future.”

This research study reveals the role of CD8+ T cells and their associated mechanisms that lead to the rejection of human iPS-derived cell products. With a patient-centric approach and due consideration of immunosuppressive strategies, hiPS-CM sheets transplant may prove to be a life-saving intervention for patients with end-stage heart failure.

Reference

Authors

Ryu Matsumotoa,b, Yin Enzhia, Kazuyoshi Takedaa,c,d, Kodai Morimotoa, Kyoko Yogoa, Masaki Haradaa, Koji Tokushigea, Yui Maeharaa, Saori Hirotaa, Yuko Kojimae, Mamoru Itof, Nagako Sougawag,h, Shigeru Miyagawag, Yoshiki Sawag, Ko Okumuraa,c,i, and Koichiro Uchidaa

Title of original paper

CD8+ T cell-mediated rejection of allogenic human-induced pluripotent stem cell-derived cardiomyocyte sheets in human PBMC-transferred NOG MHC double knockout mice

Journal

The Journal of Heart and Lung Transplantation

DOI

10.1016/j.healun.2024.04.003

Affiliations

a Center for Immune Therapeutics and Diagnosis, Juntendo University Graduate School of Medicine

b Department of Digestive Surgery, Breast and Thyroid Surgery, Graduate School of Medical and Dental Sciences, Kagoshima

University

c Department of Biofunctional Microbiota, Graduate School of Medicine, Juntendo University

d Laboratory of Cell Biology, Research Support Center, Graduate School of Medicine, Juntendo University

e Laboratory of Morphology and Image Analysis, Biomedical Research Core Facilities, Juntendo University Graduate School of Medicine

f Liver Engineering Laboratory, Department of Applied Research for Laboratory Animals, Central Institute for Experimental Animals

g Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine

h Department of Physiology, Osaka Dental University

I Atopy (Allergy) Research Center, Graduate School of Medicine, Juntendo University

About Ph.D. student Ryu Matsumoto

Ryu Matsumoto, a Ph.D. student at the Center for Immune Therapeutics and Diagnosis, Juntendo University Graduate School of Medicine, Tokyo, Japan, and also a surgeon in Department of Digestive Surgery, Breast and Thyroid Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan, specializes in human induced pluripotent stem cells, transplantation, and immunology. His research has yielded six publications in prestigious, high-impact factor journals.

About Visiting Assistant Professor Yin Enzhi

Yin Enzhi serves as a Visiting Assistant Professor in the Center for Immune Therapeutics and Diagnosis, Juntendo University Graduate School of Medicine, Tokyo, Japan. His research primarily focuses on heart transplantation, cardiac allograft survival, and stem-cell therapies.

END

[Attachments] See images for this press release:

Immunogenicity of human-induced pluripotent stem cell-derived cardiomyocyte sheets 2

Immunogenicity of human-induced pluripotent stem cell-derived cardiomyocyte sheets 3

ELSE PRESS RELEASES FROM THIS DATE:

Unravelling a mechanism of Group 2 innate lymphoid immune cell development

2024-07-10

Overproduction of Group 2 innate lymphoid cells or ILC2s—a type of white blood cells—can sometimes exacerbate conditions such as bronchial asthma, chronic rhinosinusitis, atopic dermatitis, and organ fibrosis through an exaggerated immune response. Although there are immunomodulatory drugs that can suppress Type 2 helper T (Th2) cells, drugs capable of suppressing ILC2s are currently lacking. Now, however, in a breakthrough study that could lead to the development of a new therapeutic strategy targeting ILC2s, researchers led by Associate Professor Arifumi Iwata of the Chiba University Hospital, Japan, have identified molecular ...

Award for Excellence in Natural Product Chemistry to Ricardo Riguera

2024-07-10

The Specialised Group on Chemistry of Natural Products (GQPN) of the Spanish Royal Society of Chemistry (RSEQ) has awarded its Excellence in Research Award 2023 to Professor Ricardo Riguera. The Evaluation Committee thus recognises his valuable contribution to this area of chemistry. Among other advances, his work has made it possible to describe a large number of bioactive metabolites, such as the first heptacyclopeptide and the first cyclodepsipeptide isolated from marine organisms. Riguera also identified one of the first examples of cytotoxic metabolites from marine bacteria, the first description of L-galactose as part of a natural product, and the first description ...

Researchers develop an AI model that predicts Continuous Renal Replacement Therapy survival

2024-07-10

FINDINGS A UCLA-led team has developed a machine-learning model that can predict with a high degree of accuracy the short-term survival of dialysis patients on Continuous Renal Replacement Therapy (CRRT). BACKGROUND CRRT is a therapy used for very sick hospitalized patients whose health status makes them ineligible for regular hemodialysis. It is a gentler therapy that provides continuous treatment over a prolonged period. About half of adults placed on CRRT, however, do not survive, rendering the treatment futile for both patients ...

Living in poverty due to mental health problems or developing mental health problems because of poverty? It's both.

2024-07-10

Poverty and mental illness are not only linked, but there is also a causal relationship. This is the conclusion of researchers from Amsterdam UMC, the University of Edinburgh and the University of Modena. Their study shows that while certain mental health issues can hinder financial stability, poverty is also one of the causal factors leading to mental health problems. This study was published today in Nature Human Behaviour. "This study indicates that certain mental health problems can make a person's financial situation uncertain. But conversely, we also see that poverty can lead to mental health problems," ...

Atlas of proteins reveals inner workings of cells

2024-07-10

Scientists at the University of Cambridge have developed an atlas of proteins describing how they behave inside human cells. This tool could be used to search for the origins of diseases which are related to proteins misbehaving such as dementia and many cancers. The atlas, which is published in Nature Communications, has allowed the researchers to find new proteins inside cells that are responsible for a range of important bodily functions. The team focuses on a droplet-like part of the cell called a condensate ...

Discovery of a new defense mechanism in bacteria

2024-07-10

When confronted with an antibiotic, toxic substance, or other source of considerable stress, bacteria are able to activate a defence mechanism using cell-to-cell communication to ‘warn’ unaffected bacteria, which can then anticipate, shield themselves and spread the warning signal. This mechanism1 has just been described for the first time by a team of scientists2 from CNRS and Université de Toulouse III – Paul Sabatier. It paves the way for the development of new, more effective antibiotic treatments that can target this bacterial communication system. When they perceive a source of stress, bacteria spring into action, inducing changes in the expression of certain ...

Mozambican Woodlands could store more than double the carbon previously estimated

2024-07-10

The capacity of Mozambican woodlands to capture and store carbon is underestimated and potentially undervalued for their protection and restoration, finds new research from an international team of scientists including UCL researchers and led by carbon data provider Sylvera. The research, published in Nature Communications Earth & Environment, found that miombo woodlands, which span large areas of Sub-Saharan Africa, store 1.5 to 2.2 times more carbon than had previously been estimated by standard methods. Named for the miombo trees found in the region, these biomes (geographical areas defined by their local species and ...

Cutting farm nitrous oxide emissions helps climate and ozone layer

2024-07-10

Cutting farm nitrous oxide emissions helps climate and ozone layer Adding crushed basalt rocks and special fertilisers can reduce potent nitrous oxide (N2O) greenhouse gas emissions and safeguard the stratospheric ozone layer, which protects us from harmful UV light and reduces nitrate leaching into water bodies protecting ecosystems and human health The new study, led by researchers at the University of Sheffield, highlights methods for reducing N2O emissions, such as enhanced weathering of agricultural soils with ...

Blood cancer drug could make radiotherapy on brain tumours more effective

2024-07-10

Drugs developed to fight blood and other cancers could also help improve the efficiency of radiotherapy in the most commonly diagnosed low-grade brain tumour in adults, a new study has found. Meningioma account for approximately 36% of all primary brain tumours. The majority are successfully treated by surgery, but some which can’t easily be accessed need to be treated with radiotherapy. That can cause significant side effects and radiation damage to the brain, while resistance to radiotherapy can also result in tumour growth. A new study by researchers at the Brain Tumour Research ...

Does air pollution affect lupus risk?

2024-07-10

New research published in Arthritis & Rheumatology indicates that chronic exposure to air pollutants may increase the risk of developing lupus, an autoimmune disease that affects multiple organs. For the study, investigators analyzed data on 459,815 participants from the UK Biobank. A total of 399 lupus cases were identified during a median follow-up of 11.77 years. Air pollutant exposure was linked with a greater likelihood of developing lupus. Individuals with a high genetic risk and high air pollution exposure had the highest risk of developing ...

Immunogenicity of human-induced pluripotent stem cell-derived cardiomyocyte sheets

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: